IOLCP — IOL Chemicals and Pharmaceuticals Cashflow Statement
0.000.00%
- IN₹38.65bn
- IN₹37.91bn
- IN₹23.19bn
Annual cashflow statement for IOL Chemicals and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 2,249 | 1,887 | 1,817 | 1,380 | 1,844 |
| Depreciation | |||||
| Non-Cash Items | -101 | -17.5 | -27.9 | 78.6 | 48.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1,650 | -1,108 | 483 | -392 | -551 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 931 | 1,223 | 2,901 | 1,786 | 2,143 |
| Capital Expenditures | -1,533 | -2,118 | -2,742 | -2,136 | -1,730 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 331 | 918 | 829 | 594 | -251 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,202 | -1,200 | -1,913 | -1,542 | -1,981 |
| Financing Cash Flow Items | -81.1 | -164 | -161 | -148 | -145 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -16.4 | -41.1 | -925 | 460 | -290 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -288 | -18.4 | 63 | 705 | -128 |